![Ming Hao Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ming Hao Sun
Chief Tech/Sci/R&D Officer at
CAPRICOR THERAPEUTICS, INC.
Profile
Ming Hao Sun is Senior Vice President-Quality Control & Research at Capricor Therapeutics, Inc. since 2021.
Former roles include Director-Stem Cell Research at Trans Ova Genetics LC from 2019 to 2020 and General Manager-San Diego Site at Precigen, Inc. from 2012 to 2019.
Education includes a doctorate from The Pennsylvania State University and undergraduate and graduate degrees from Wuhan University.
Ming Hao Sun active positions
| Companies | Position | Start |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Ming Hao Sun
| Companies | Position | End |
|---|---|---|
Trans Ova Genetics LC
 Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Corporate Officer/Principal | 2020-04-30 |
| PRECIGEN, INC. | Corporate Officer/Principal | 2019-07-31 |
Training of Ming Hao Sun
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Health Technology |
- Stock Market
- Insiders
- Ming Hao Sun
